Dr. Mark Robert Keaton, MD

Dr. Keaton practices at Wilcox Medical Center in Lihue, Hawaii, part of Hawaiʻi Pacific Health.

Dr. Keaton's NPI, 1477530533, was assigned on December 29, 2005. Dr. Keaton graduated from Medical College of Georgia in 1983. Dr. Keaton's South Carolina license number on file is 51420.

Dr. Keaton's primary practice is Wilcox Medical Center, at 3-3420 Kuhio Highway, Lihue, HI 96766 in Kauai County. The practice phone is (808) 245-1100.

Dr. Keaton's primary practice is Wilcox Medical Center in Lihue, Hawaii, part of Hawaiʻi Pacific Health. Dr. Keaton is also affiliated with Marshfield Medical Center - Marshfield. The medical group on file is Kauaʻi Medical Clinic. Dmand AI also links Dr. Keaton to 3 more hospitals, 9 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keaton practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Keaton's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Keaton is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Keaton's licenses on file in 10 states: South Carolina, South Dakota, Colorado, Georgia, Montana, Hawaii, Wisconsin, Wyoming, West Virginia and Idaho.

Dmand AI lists breast cancer, chronic anemia, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Keaton treats.

CMS data shows 16 Medicare services from Dr. Keaton across 1 procedure code in 2024, all of them office visits, for 27 Medicare patients. Medicare paid $1,153 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 27 Medicare patients who saw Dr. Keaton in 2024. The largest group is 65 to 74, with 13 patients. 75% of them have high blood pressure, and 70% have high cholesterol. Their average risk score is 2.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Keaton's median patient age at 75, with 48% women.

In 2024, Dr. Keaton wrote 99 Medicare Part D claims for 34 patients. 83% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $461 in total drug cost. In 2021, CMS named 35 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Keaton for performance year 2024, reported as part of a group. Dr. Keaton accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 15 papers to Dr. Keaton, published from 2009 to 2017. 2011 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Antibodies, Monoclonal, Humanized and Bevacizumab. Dr. Keaton has published most often in Clin Breast Cancer. Dr. Keaton's most frequent co-authors are Lee S. Schwartzberg, MD, John D. Hainsworth, MD and Joyce Ann O'Shaughnessy, MD.

Dmand AI links Dr. Keaton to 2 clinical trials. Conditions studied include Carcinoma, Non-Small-Cell Lung, Leukemia, Lymphocytic, Chronic, B-Cell and Carcinoma, Bronchogenic.

CMS Open Payments shows 660 general payments to Dr. Keaton from 49 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. AstraZeneca Pharmaceuticals LP paid the most, $13,956.

Dmand AI lists 3 awards for Dr. Keaton, most recently Regional Top Doctor in 2014.

Dr. Keaton graduated from Medical College of Georgia in 1983.

Dr. Keaton is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.